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Objective: To stratify major hepatectomies (MajHs) according to their out-
comes.
Summary of Background Data: MajHs are associated with non-negligible
operative risks, but they include a wide range of procedures. Detailed
depiction of the outcomes of different MajHs is the basis for a new classifi-
cation of liver resections.
Methods: We retrospectively considered patients that underwent hepatec-
tomy in 17 high-volume centers. Patients with an associated digestive/biliary
resection were excluded. We analyzed open MajHs in non-cirrhotic patients.
MajHs were classified according to the Brisbane nomenclature. Right hepa-
tectomies (RHs) were reference standards. Outcomes were adjusted for
potential confounders, including indication, liver function, preoperative portal
vein embolization, and enrolling center.
Results: We analyzed a series of 2212 patients. In comparison with RH, left
hepatectomy had lower mortality [0.6% vs 2.2%, odds ratio (OR) ¼ 0.25],
severe morbidity (11.7% vs 14.4%, OR ¼ 0.62), and liver failure rates (2.1%
vs 11.6%, OR ¼ 0.16). Left hepatectomyþSg1 and mesohepatectomyþ/
Sg1 had outcomes similar to RH, except for higher bile leak rate (31.3% and
13.5% vs 6.7%, OR ¼ 4.36 and OR ¼ 2.29). RHþSg1 had slightly worse
outcomes than RH. Right and left trisectionectomies had higher mortality
(5.0% and 7.3% vs 2.2%, OR ¼ 2.07 and OR ¼ 2.71) and liver failure rates
than RH (19.0% and 22.0% vs 11.6%, OR ¼ 2.03 and OR ¼ 2.21). Left
trisectionectomy had even higher severe morbidity (25.6% vs 14.4%, OR ¼
2.07) and bile leak rates (14.6% vs 6.7%, OR ¼ 2.31).
Conclusions: The term ‘‘major hepatectomy’’ includes resections having
heterogeneous outcome. Different MajHs can be stratified according to their
mortality, severe morbidity, liver failure, and bile leak rates.
Keywords: bile leak, classification of hepatectomies, extended hepatectomy,
liver failure, liver surgery, major hepatectomy, postoperative mortality, right
hepatectomy, severe morbidity
(Ann Surg 2020;272:827–833)
I n past decades, liver surgery has been characterized by a progres-sive improvement of operative outcomes, enlargement of indica-
tions and performance of more and more complex resections.1–5
Major hepatectomies (MajH) are still associated with non-negligible
operative risks but became safer thanks to preoperative measurement
of volume of future liver remnant and to its modulation whenever
inadequate.6–9 Further, new risk factors, such as patients’ sarcopenia
and frailty and underlying liver diseases other than cirrhosis, have
been identified leading to a more accurate selection of candidates.10–
15 In this scenario, a proper classification of hepatectomies is
mandatory to enable an adequate comparison among surgical series,
to correctly predict outcome and communicate risk to patients, to
define appropriate benchmarks, and to plan modular hepatic surgery
training curriculum.
The term ‘‘major hepatectomy’’ is outdated because encom-
passes heterogeneous procedures ranging from standard left hepa-
tectomy (LH) to trisectionectomies extended to segment (Sg) 1. The
definition itself of MajH has been criticized because the cut-off of 3
segments is too low.16,17 Further, even if the volume of resected liver
is strongly associated with postoperative outcome,5,9 it does not
necessarily predict complications other than liver failure.
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Some proposals have been advanced, but none have fulfilled
expectations. Kawaguchi et al designed a classification for mini-
mally-invasive liver resections, but focused attention on minor
hepatectomies.18 Lee et al proposed a more complete classification,
but they stratified procedures according to perceived complexity
assessed by a worldwide survey of experts.19,20 The Classification of
Liver Surgery on Complexity and Outcome (CLISCO) group
recently published a classification of minor hepatectomies based
on the analysis of multiple outcomes, that is, severe morbidity, bile
leak, and liver failure rates.21 Some ‘‘minor’’ hepatectomies had
outcome even similar to right hepatectomy (RH). The present study
aimed to complete the picture. We analyzed a large series of patients
without cirrhosis that underwent open MajH in high-volume centers
to elucidate the outcome of different types of resection and to
propose a classification of MajHs accordingly.
METHODS
We retrospectively collected data for all consecutive patients
that underwent a first liver resection in 17 international high-volume
centers (Supplementary Table 1, http://links.lww.com/SLA/C457)
during 2004–2014. Some centers obtained a protocol amendment
to shorten the enrollment period, but all inclusions comprised a series
of consecutive patients. Exclusion criteria were: digestive or biliary
resection associated with hepatectomy; emergency resection; and
repeated hepatectomy. The cohort included 10,770 patients. We
considered the 3057 patients that underwent MajH. We further
excluded patients that underwent MajH in a cirrhotic liver (n ¼
307); MajH as the second stage of staged hepatectomy (staged MajH,
n ¼ 297); or minimally-invasive MajH (n ¼ 261, including 11
cirrhotic patients and 9 staged MajHs). For the present study, we
analyzed 2212 non-cirrhotic patients that underwent open MajH.
The study was approved by the local ethical committees and
the requirement of informed consent was waived.
Study Design
The following main outcomes were analyzed: 90-day mortal-
ity, severe morbidity, liver failure, and bile leak. Operative mortality
was defined as death occurred during hospitalization or within
90 days after surgery. The Dindo-Clavien classification was used;
any complication of grade 3 was classified as severe morbidity.22
We used the International Study Group of Liver Surgery definition of
postoperative liver failure and bile leak.23,24 Additional endpoints
were overall morbidity, comprehensive complication index (CCI),
blood transfusion, and hospital stay time. Overall morbidity was
classified as any deviation from standard postoperative recovery. CCI
was computed with an online calculator according to Slankamenac
et al.25,26 CCI computation was based on retrospective review of
postoperative complications (potential underestimation of minor
complications). Blood transfusions included both intraoperative
and postoperative transfusions. Blood loss was not analyzed, because
the data were not available for all patients, and the method of
computing blood loss differed among centers.
The outcomes of different MajHs were compared with those of
RH, the most standardized MajH. RHs performed in the same centers
during the same period were used as reference standard (n ¼ 1042).
We evaluated both unadjusted associations between the different
procedures and outcomes, and associations between resection types
and outcomes after adjustment for covariates (see Statistical analy-
sis).
Resections were classified according to the Brisbane nomen-
clature27: RH, LH, mesohepatectomy [resection of segments (Sg) 4–
5–8], right trisectionectomy, and left trisectionectomy. For each type
of hepatectomy, we considered the extension or not of resection to
Sg1. The 2 procedures (with or without Sg1) were analyzed sepa-
rately if the number of patients was adequate (>50 patients in each
group). Mesohepatectomy, right trisectionectomy, and left trisectio-
nectomy groups had a low number of patients that precluded the
possibility to separately consider resections with or without exten-
sion to Sg1. Consequently, we analyzed mesohepatectomyþ/ Sg1,
right trisectionectomy þ/ Sg1, and left trisectionectomy þ/ Sg1.
All groups were determined a priori, before explorative analyses.
Statistical Analysis
Continuous variables were assessed graphically to determine
distribution normality, and they were evaluated with parametric
(unpaired t-test) or non-parametric (Mann-Whitney U-test) tests,
accordingly. Categorical variables were assessed with the Chi-square
or Fisher exact tests, as appropriate. Association between different
MajHs and outcomes was analyzed by a multivariable logistic-
regression model, adjusting data for the following potential con-
founders: age; the American Society of Anesthesiologists (ASA)
score; hepatitis B virus/hepatitis C virus (HBV/HCV) infection;
preoperative chemotherapy; diagnosis (indication to surgery);
TABLE 1. Patients’ Characteristics
Whole Series N ¼ 2212
N (%) – Mean; Median (IQR)







Cardiovascular diseasesz,§ 768 (37.8)
Diabetes 309 (15.1)
COPDjj 111 (5.5)









Preoperative chemotherapy 753 (34.8)
Total bilirubin (mg/dL)yy 0.76; 0.61 (0.46–0.90)
Albumin (g/L)zz 4.0; 4.0 (3.7–4.3)
INR§§ 1.05; 1.02 (1.00–1.10)
AST (UI/L) 53; 30 (22–45)
Creatinine (mg/dL)jjjj 0.93; 0.83 (0.70–1.02)
Available in 2209 patients.
yAvailable in 2029 patients.
zAvailable in 2031 patients.
§Cardiovascular diseases include also arterial hypertension.
Available in 2053 patients.
jjAvailable in 2031 patients.
Available in 2166 patients.
yyAvailable in 1839 patients.
zzAvailable in 1036 patients.
§§Available in 1411 patients.
Available in 1801 patients.
jjjjAvailable in 1772 patients.
ASA indicates American Society of Anesthesiologists; AST, aspartate
aminotransferase; CLM, colorectal liver metastasis; COPD, chronic obstructive
pulmonary disease; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV,
hepatitis C virus; ICC, intrahepatic cholangiocellular carcinoma; INR, international
normalized ratio; IQR, interquartile range.
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preoperative total bilirubin and aspartate aminotransferase (AST)
values; preoperative portal vein occlusion; and the enrolling center.
Age, preoperative total bilirubin values, and preoperative AST values
were included in the multivariable model as continuous variables. No
imputation of missing data was performed. We tested the statistical
interaction between each exposure and center by comparing the
models with and without interaction by the likelihood ratio test.
Operative time and blood loss were not included because they were
considered mediators in the pathway between MajH and outcome
rather than confounders (they do not have an impact on both exposure
and outcome). In addition, operative time and blood loss values were
largely heterogeneous among centers (different surgical policies and
heterogeneity in blood loss computation). Preoperative INR and
albumin values were not included due to missing data. The number
of predictors included was limited to ensure model parsimony, as
suggested by Harrell et al.28 All analyses were performed with Stata
15 software.
RESULTS
We analyzed data of 2212 patients that underwent open MajH
in a non-cirrhotic liver, including 1042 that underwent RH. Tables 1
and 2 summarize patients’ characteristics, procedures, and out-
comes. Overall, mortality rate was 2.3% (50/2212, median value
across centers 2.0%). It progressively increased with the number of
resected segments (0.8% if 3 segments, 2.1% if 4, and 5.7% if>4, P
¼ 0.005). The same progressive increase was observed for severe
morbidity (11.7% vs 15.4% vs 21.0%, P < 0.001) and liver failure
rates (2.6% vs 11.5% vs 21.0%, P < 0.001). Bile leak rate was
associated with the resection of Sg1 (22.4% if resected vs 7.7% if
not, P< 0.001) and of Sg4 (11.0% vs 7.3%, respectively, P¼ 0.002),
but not with the number of resected segments. Figure 1 shows
the association between the number of resected segments
and outcomes.
Figure 2 summarizes the adjusted odds ratio (OR) for main
outcomes of different MajHs. Supplementary Tables 2–5, http://link-
s.lww.com/SLA/C457 summarize results of multivariable analyses.
RH had 90-day mortality rate of 2.2% and severe morbidity rate of
14.4%. In comparison with RH, LH was associated with lower
mortality [0.6%, OR ¼ 0.254, 95% confidence intervals (95% CI)
¼ 0.085–0.757, P¼ 0.014] and severe morbidity rates (11.7%, OR¼
0.624, 95% CI¼ 0.409–0.953, P ¼ 0.029), whereas left trisectionec-
tomy was associated with higher 90-day mortality (7.3%, OR¼ 2.706,
95% CI¼ 1.000–7.321, P¼ 0.050) and severe morbidity rates (25.6%,
OR ¼ 2.065, 95% CI ¼ 1.081–3.947, P ¼ 0.028). LH þ Sg1 and
mesohepatectomy had mortality and severe morbidity rates similar to
RH. RH þ Sg1 and right trisectionectomy were associated with
slightly higher 90-day mortality rate than RH (5.7% and 5%, OR ¼
2.5 and OR ¼ 2.1, respectively, P > 0.05 for both); RH þ Sg1 had
TABLE 2. Comparison of Outcomes of Different Procedures: 90-d Mortality, Severe Morbidity, Bile Leak, and Postoperative
Liver Failure
90-d Mortality Severe Morbidity Bile Leak
Postoperative Liver
Failure
Procedure # N (%)
P versus
Right hep. N (%)
P versus
Right hep. N (%)
P versus
Right hep. N (%)
P versus
Right hep.
Right hepatectomy 1042 23 (2.2) — 150 (14.4) — 70 (6.7) — 121 (11.6) —
Left hepatectomy 624 4 (0.6) 0.014 73 (11.7) 0.118 51 (8.2) 0.268 13 (2.1) <0.001
Left hepatectomy þ Sg1 83 1 (1.2) 0.543 21 (25.3) 0.008 26 (31.3) <0.001 8 (9.6) 0.587
Right hepatectomy þ Sg1 70 4 (5.7) 0.065 21 (30.0) <0.001 11 (15.7) 0.005 18 (25.7) 0.001
Mesohepatectomy þ/ Sg1 111 2 (1.8) 0.780 15 (13.5) 0.801 15 (13.5) 0.009 6 (5.4) 0.047
Left trisectionectomy þ/ Sg1 82 6 (7.3) 0.005 21 (25.6) 0.007 12 (14.6) 0.008 18 (22.0) 0.006













FIGURE 1. Outcomes of major hepatectomies according to the number of resected segments. Bile leak risk is separately analyzed
for patients with and without resection of Sg1.
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even slightly higher severe morbidity rates (30%, OR ¼ 1.825, P ¼
0.098).
Liver failure rate after RH was 11.6%. LH was associated with
lower liver failure rates than RH (2.1%, OR ¼ 0.159, 95% CI ¼
0.079–0.321, P < 0.001), whereas right trisectionectomy and left
trisectionectomy were associated with higher rates (19.1%, OR ¼
2.028, 95% CI¼ 1.174–3.502, P¼ 0.011; 22.0%, OR¼ 2.213, 95%
CI ¼ 1.074–4.559, P ¼ 0.031, respectively). Mesohepatectomy was
associated with slightly lower liver failure rate than RH (5.4%, OR¼
0.348, P ¼ 0.055).
LH and right trisectionectomy had bile leak rates similar to
RH, whereas RHþ Sg1 was associated with slightly higher bile leak
rate than RH (15.7% vs 6.7% after RH, OR ¼ 2.003, P ¼ 0.084). All
the remaining MajHs were associated with higher bile leak rate than
RH (LH þ Sg1, 31.3%, OR ¼ 4.357, 95% CI ¼ 2.280–8.326, P <
0.001; mesohepatectomy, 13.5%, OR ¼ 2.287, 95% CI ¼ 1.145–
4.568, P ¼ 0.019; and left trisectionectomy, 14.6%, OR ¼ 2.314,
95% CI ¼ 1.112–4.816, P ¼ 0.025).
Considering overall morbidity, LH was associated with lower
rates than RH (35.9% vs 44.0%, OR ¼ 0.595, 95% CI ¼ 0.441–
0.802, P ¼ 0.001), whereas RH þ Sg1, left trisectionectomy and
right trisectionectomy were associated with higher rates (72.9%, OR
¼ 2.582, 95% CI ¼ 1.357–4.909, P ¼ 0.004; 52.4%, OR ¼ 1.866,
95% CI ¼ 1.071–3.252; 54.6%, OR ¼ 1.565, 95% CI ¼ 1.031–
2.376, P ¼ 0.035, respectively, Supplementary Fig. 1, http://link-
s.lww.com/SLA/C457).
There was no evidence of interaction between each exposure
and center when comparing the models with and without interaction
by the likelihood ratio test (P > 0.05).
At univariate analysis (Supplementary Table 6, http://link-
s.lww.com/SLA/C457), LH had lower CCI values than RH (10.9 vs
13.4, P¼ 0.025), whereas RHþ Sg1, right trisectionectomy and left
FIGURE 2. Adjusted odds ratio for 90-day mortality (A), severe morbidity (B), liver failure (C), and bile leak (D) of different major
hepatectomies versus right hepatectomy (RH). The following variables were included in the multivariable model to compute the
adjusted odds ratio: age; ASA score; HBV/HCV infection; preoperative chemotherapy; diagnosis (indication to surgery); preopera-
tive total bilirubin and AST values; preoperative portal vein occlusion; and the enrolling center. The figures refer to odds ratio and
95% confidence intervals. ASA indicates American Society of Anesthesiologists; AST, aspartate aminotransferase; HBV, hepatitis B
virus; HCV, hepatitis C virus; LH, left hepatectomy; Mesohep, mesohepatectomy; Sg, segment.
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trisectionectomy had higher values (24.3, P < 0.001; 18.2, P ¼
0.007; and 25.7, P < 0.001, respectively). LH had lower transfusion
rate than RH (14.8% vs 23.2%, P < 0.001) and shorter hospital stay
(11% vs 13.4 days, P < 0.001), whereas RH þ Sg1 and right
trisectionectomy had higher transfusion rates (37.7%, P ¼ 0.007
and 31.9%, P ¼ 0.025) and longer hospital stay (17.4 days, P ¼
0.009, and 15.5 days, P ¼ 0.040, respectively).
Classification of MajHs according to their main outcomes
is summarized in Table 3. On the basis of mortality, severe
morbidity, liver failure, and bile leak rates, MajHs can be
classified into 3 groups: low-risk MajHs, that is, LH; intermedi-
ate-risk MajHs, that is, RH, LH þ Sg1, and mesohepatectomy þ/
Sg1; and high-risk MajHs, that is, RH þ Sg1, and trisectionectomies
þ/ Sg1.
DISCUSSION
Despite major evolution of liver surgery occurred in past
decades, surgeons still adopt the definition of MajHs established in
early ‘90s.29 Some authors suggested an update, moving the term
‘‘major hepatectomy’’ to the resection of 416 or 5 segments,17 but
they did not gain wide consensus. The number of resected segments is a
poor surrogate of liver volume. We highlighted 2 further limitations of
that definition. First, it is not possible to identify a single cut-off value
of resected segments to stratify mortality, liver dysfunction, and severe
morbidity. Second, the number of resected segments does not predict
some clinically relevant outcomes, such as bile leak.
New approaches to classification of hepatectomies have been
proposed, but they failed to adequately stratify MajHs. Both the Iwate
score and the Halls et al score classified all MajHs as advanced
procedures.30,31 Kawaguchi et al assigned all MajHs except for LH
to the group of most complex resections,18 but both the original
laparoscopic series by Kawaguchi et al and a recent validation analysis
in open hepatectomies reported heterogeneous outcomes for different
MajHs.18,32 Lee et al proposed a more detailed stratification of MajHs
based on perceived complexity and difficulty of procedures.19,20
However, as demonstrated by Jang et al,33 complexity does not
necessarily correspond to outcome. We followed a different path:
we identified all types of MajH, analyzed their clinically relevant
outcomes, and, accordingly, proposed a classification.
Present results allowed a clear stratification of MajHs. LH was
a standardized low-risk resection with excellent outcome, better than
those of RH and similar to those that we reported for anterolateral
FIGURE 2. (Continued).
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segmentectomies and complex limited resections.21 As previously
suggested,16–18 LH should be no longer considered a MajH. RH, the
commonest procedure, had quite low mortality and liver failure rates
(2% and 12%, respectively). For the remaining MajHs the scenario
was much more complex. Procedures are less standardized: despite
the collection of data through 17 high-volume centers, most hepa-
tectomies did not reach 100 cases. As we previously demonstrated for
minor hepatectomies,21 bile leak was an issue, especially for left-
sided resections extended to Sg1. Surgery of perihilar segments,
namely Sg1 and Sg4, has been associated with biliary complica-
tions.34–37 During Sg1 resection multiple bile ducts converging into
the biliary confluence have to be accurately identified and tied.
Further, some interrupted bile ducts from residual parts of Sg1 may
lead to long-lasting and difficult-to-heal bile leakage. RHþSg1 was
also associated with increased severe morbidity and mortality rates in
comparison with RH. The extension of resection to Sg1 requires deep
dissection with difficult visualization of the transection plane. It
could lead to some vascular or biliary injuries. In addition, paren-
chyma sacrifice could be underestimated, especially when complete
Sg1 resection was not scheduled a priori. Finally, we analyzed a large
number of trisectionectomies without biliary anastomosis, proce-
dures poorly depicted in the literature. Their mortality risk was high
(over 5%) and liver failure occurred in about one-fifth of patients,
despite the adoption of preoperative portal vein embolization when
future liver remnant was considered inadequate. Results were even
worse after left trisectionectomy, a rare procedure (3% of MajHs,
<1% of the whole series), technically complex and rarely considered
for preoperative portal vein embolization. Unfortunately, data did not
allow to separately consider trisectionectomies extended or not
to Sg1.
The present results are clinically relevant because, thanks to a
large series of patients collected through 17 high-volume centers, we
effectively stratified the outcome of MajHs and proposed a new
classification accordingly. Present analysis was based on the Bris-
bane nomenclature,27 a shared language among surgeons. We
highlighted major limitations of standard classification of hepatec-
tomies and of recent new proposals. In fact, our results did not match
with the classification proposed by Lee et al who only distinguished
medium- (LHþ/ Sg1, RH, right trisectionectomy without Sg1) and
high-complexity resections (the remaining MajHs).19,20 We identi-
fied 3 groups of procedures according to their outcomes: low-risk
MajHs, that is, LH; intermediate-risk MajHs, that is, RH, LHþ Sg1,
and mesohepatectomy þ/ Sg1; and high-risk MajHs, that is, RH þ
Sg1 and trisectionectomiesþ/ Sg1. Finally, present data completed
those we published about minor liver resections21: their combination
should represent the strong background for a new classification of all
the hepatectomies.
Some limitations of our study could be argued, such as its
retrospective design and the heterogeneous cohort of patients from
different centers. However, outcomes were adjusted for covariates,
including differences among centers. The most standardized MajH
(RH) was used as reference. The analysis of future liver remnant
volume would have been an additional point to stratify outcome and
liver failure risk,6–9 but we adjusted data for preoperative portal vein
embolization, an acceptable surrogate of inadequate liver volume.
Further parameters could refine estimation of the operative risk, such
as BMI, sarcopenia and frailty, and underlying liver disease,10–15 but
we focused our analysis on standardized parameters that were
available in the database. Some procedures were grouped together
to have an adequate number of patients, precluding specific
TABLE 3. Classification of Major Hepatectomies According to Their Outcomes
Risk of 































Right hepatectomy Intermediate Intermediate Intermediate Intermediate 
Left hepatectomy + Sg1 
Mesohepatectomy +/- Sg1 




Right hepatectomy + Sg1 Intermediate/high Intermediate/high Intermediate/high Intermediate 
Right trisectionectomy +/- Sg1 Intermediate/high Intermediate Intermediate High 
Left trisectionectomy +/- Sg1 High High High High 
The definitions of low, intermediate and high risk of complications were based on the adjusted odds ratios for postoperative 90-day mortality, severe morbidity, liver 
failure and bile leak of different major hepatectomies in comparison with RH. The risk was defined as low (green) if lower than RH, as intermediate (yellow) if 
similar to RH, intermediate/high (orange) if slightly higher than RH and high (red) if higher than RH. According to our previous publication [21], the risk of liver 
failure was defined as intermediate (yellow) if approaching RH or similar to it.
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evaluations. Liver resections with associated biliary anastomosis
were not included. Even if they would have completed the picture
of MajHs, they present preoperative and postoperative peculiarities
(jaundice, risk of biliary drain-related sepsis, bile leak from bilio-
enteric anastomosis) that require dedicated analyses. Finally, exter-
nal validation in prospective series is needed as well as evaluation of
present results in patients with cirrhosis and in those undergoing
minimally-invasive surgery.
In conclusion, the term ‘‘major hepatectomy’’ is outdated
because encompasses several types of resections with heterogeneous
outcome. While liver surgeons extended indications, learned to
modulate liver volume and refined patients’ selection, a modern
and reliable classification cannot be simply based on the number of
resected segments or on a single outcome. MajHs should be stratified
according to the risk of mortality, severe morbidity, bile leak, and
liver failure.
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2. Torzilli G, Viganò L, Gatti A, et al. Twelve-year experience of ‘‘radical but
conservative’’ liver surgery for colorectal metastases: impact on surgical
practice and oncologic efficacy. HPB. 2017;19:775–784.
3. Zimmitti G, Roses RE, Andreou A, et al. Greater complexity of liver surgery is
not associated with an increased incidence of liver-related complications
except for bile leak: an experience with 2,628 consecutive resections. J
Gastrointest Surg. 2013;17:57–64.
4. de Haas RJ, Wicherts DA, Andreani P, et al. Impact of expanding criteria for
resectability of colorectal metastases on short- and long-term outcomes after
hepatic resection. Ann Surg. 2011;253:1069–1079.
5. Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome
after hepatic resection: analysis of 1,803 consecutive cases over the past
decade. Ann Surg. 2002;236:397–406.
6. Rassam F, Olthof PB, van Lienden KP, et al. Functional and volumetric
assessment of liver segments after portal vein embolization: differences in
hypertrophy response. Surgery. 2019;165:686–695.
7. Shindoh J, Tzeng CW, Aloia TA, et al. Portal vein embolization improves rate
of resection of extensive colorectal liver metastases without worsening
survival. Br J Surg. 2013;100:1777–1783.
8. Omichi K, Yamashita S, Cloyd JM, et al. Portal vein embolization reduces
postoperative hepatic insufficiency associated with postchemotherapy hepatic
atrophy. J Gastrointest Surg. 2018;22:60–67.
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